Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

22
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
22
Decreased Body Temperature01:29

Decreased Body Temperature

647
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
647
Methods of reducing fever01:22

Methods of reducing fever

699
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
699
Increased Body Temperature01:25

Increased Body Temperature

707
A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
707
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

20
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
20
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

[Key Symptoms in the Emergency Department: Fever].

Deutsche medizinische Wochenschrift (1946)·2026
Same author

[Updated management algorithm: non-invasive ventilation (NIV)].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same author

[Geriatric care assistance in emergency departments: position paper of DGIIN, DGINA, and DGG].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same author

[Evaluation of the TriageClient digital decision support system for the sectoral allocation of emergency patients in an integrated emergency center : A secondary data analysis].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same author

[Action algorithm: management of electrical injury in acute and emergency medicine].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same author

Incidence and risk factors for cardiac arrest following upper cervical spine fractures in the elderly after minor trauma.

Archives of orthopaedic and trauma surgery·2026

Related Experiment Video

Updated: Jul 18, 2025

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

24.4K

[Targeted temperature management after cardiac arrest].

Sandra Finkbeiner1, Katrin Fink1, Hans-Jörg Busch1

  • 1Zentrum für Notfall- und Rettungsmedizin, Universitätsklinikum Freiburg, Freiburg im Breisgau, Deutschland.

Deutsche Medizinische Wochenschrift (1946)
|August 23, 2023
PubMed
Summary

Avoiding fever after cardiac arrest is crucial for neurological recovery. Recent guidelines suggest only fever prevention, not strict hypothermia, may be beneficial, but more research is needed for personalized treatment.

More Related Videos

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

3.1K
Establishment of Deep Hypothermic Circulatory Arrest in Rats
08:39

Establishment of Deep Hypothermic Circulatory Arrest in Rats

Published on: December 16, 2022

2.3K

Related Experiment Videos

Last Updated: Jul 18, 2025

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

24.4K
In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

3.1K
Establishment of Deep Hypothermic Circulatory Arrest in Rats
08:39

Establishment of Deep Hypothermic Circulatory Arrest in Rats

Published on: December 16, 2022

2.3K

Area of Science:

  • Neurology
  • Cardiology
  • Critical Care Medicine

Context:

  • Current guidelines for targeted temperature management (TTM) after cardiac arrest have evolved, with recent updates recommending fever avoidance over strict hypothermia.
  • The TTM2 Trial indicated no significant benefit of hypothermia (33°C) versus normothermia for survival or neurological outcome.
  • German population-specific data on bystander cardiopulmonary resuscitation (CPR) and shockable rhythms are lower, potentially limiting direct application of international trial results.

Purpose:

  • To analyze the evolving recommendations for targeted temperature management (TTM) post-cardiac arrest.
  • To discuss the implications of recent clinical trials, such as the TTM2 Trial, on TTM guidelines.
  • To highlight the need for further research to personalize TTM strategies based on patient subpopulations.

Summary:

  • Actively preventing fever post-cardiac arrest is essential for improving neurological outcomes.
  • Recent European guidelines have shifted from recommending strict hypothermia (32-36°C) to emphasizing fever avoidance within the first 72 hours.
  • The TTM2 trial found no survival or neurological benefit for hypothermia compared to normothermia, influencing these guideline changes.

Impact:

  • The findings necessitate a re-evaluation of TTM protocols in clinical practice.
  • Individualized TTM strategies may be required, considering factors specific to patient populations like those in Germany.
  • Further research is crucial to identify which patient subgroups benefit from specific temperature targets, optimizing post-cardiac arrest care.